Showing 1 to 10 of 443 records(fetched in 7.487 seconds)
TitleWorld guidelines for falls prevention and management for older adults: a global initiative.
AuthorsMontero-Odasso, M; van der Velde, N; Martin, FC; Petrovic, M; Tan, MP; Ryg, J; Aguilar-Navarro, S; Alexander, NB; Becker, C; Blain, H; Bourke, R; Cameron, ID; Camicioli, R; Clemson, L; Close, J; Delbaere, K; Duan, L; Duque, G; Dyer, SM; Freiberger, E; Ganz, DA; Gómez, F; Hausdorff, JM; Hogan, DB; Hunter, SMW; Jauregui, JR; Kamkar, N; Kenny, RA; Lamb, SE; Latham, NK; Lipsitz, LA; Liu-Ambrose, T; Logan, P; Lord, SR; Mallet, L; Marsh, D; Milisen, K; Moctezuma-Gallegos, R; Morris, ME; Nieuwboer, A; Perracini, MR; Pieruccini-Faria, F; Pighills, A; Said, C; Sejdic, E; Sherrington, C; Skelton, DA; Dsouza, S; Speechley, M; Stark, S; Todd, C; Troen, BR; van der Cammen, T; Verghese, J; Vlaeyen, E; Watt, JA; Masud, T; Kaur Ajit Singh, D; Aguilar-Navarro, SG; Aguilera Caona, E; Alexander, NB; Allen, N; Anweiller, C; Avila-Funes, A; Barbosa Santos, R; Batchelor, F; Becker, C; Beauchamp, M; Birimoglu, C; Blain, H; Bohlke, K; Bourke, R; Alonzo Bouzòn, C; Bridenbaugh, S; Gabriel Buendia, P; Cameron, I; Camicioli, R; Canning, C; Alberto Cano-Gutierrez, C; Carlos Carbajal, J; Cristina Carvalho de Abreu, D; Casas-Herrero, A; Ceriani, A; Cesari, M; Chiari, L; Clemson, L; Close, J; Manuel Cornejo Alemǻn, L; Dawson, R; Delbaere, K; Doody, P; Dsouza, S; Duan, L; Duque, G; Dyer, S; Ellmers, T; Fairhall, N; Ferruci, L; Freiberger, E; Frith, J; Gac Espinola, H; Ganz, DA; Giber, F; Fernando Gómez, J; Miguel Gutiérrez-Robledo, L; Hartikainen, S; Hausdorff, J; Hogan, DB; Hooi Wong, C; Howe, S; Hunter, S; Perez Jara, J; Jauregui, R; Jellema, A; Jenni, S; Jepson, D; Kalula, S; Kamkar, N; Kaur Ajit Singh, D; Anne Kenny, R; Kerse, N; Kobusingye, O; Kressig, R; Kwok, W; Lamb, S; Latham, N; Ling Lim, M; Lipsitz, L; Liu-Ambrose, T; Logan, P; Lord, S; Alves Lourenço, R; Madden, K; Mallet, L; Marín-Larraín, P; Marsh, DR; Martin, FC; Martínez Padilla, D; Masud, T; Mat, S; McGarrigle, L; McIlroy, B; Melgar-Cuellar, F; Menant, J; Milisen, K; Mimenza, A; Moctezuma-Gallegos, R; Montero-Odasso, M; Morris, ME; Muneeb, I; Negahban, H; Nieuwboer, A; Norris, M; Ogliari, G; Oliveira, J; Parodi, JF; Perez, S; Perracini, M; Petrovic, M; Ernesto Picado Ovares, J; Pieruccini-Faria, F; Pighills, A; Pinheiro, M; Poelgeest, E; Ramirez Ulate, X; Robinson, K; Ryg, J; Said, C; Sakurai, R; Schapira, M; Sejdic, E; Seppala, LJ; Sgaravatti, A; Sherrington, C; Skelton, D; Song, Y; Speechley, M; Stark, S; Sultana, M; Suri, A; Pin Tan, M; Taylor, M; Thomsen, K; Tiedemann, A; Lucia Tito, S; Todd, C; Troen, B; Van der Cammen, T; Van der Velde, N; Verghese, J; Vlaeyen, E; Watt, J; Welmer, AK; Won Won, C; Rixt Zijlstra, GA
JournalAge and ageing
Publication Date2 Sep 2022
Date Added to PubMed1 Oct 2022
Abstractfalls and fall-related injuries are common in older adults, have negative effects on functional independence and quality of life and are associated with increased morbidity, mortality and health related costs. Current guidelines are inconsistent, with no up-to-date, globally applicable ones present. to create a set of evidence- and expert consensus-based falls prevention and management recommendations applicable to older adults for use by healthcare and other professionals that consider: (i) a person-centred approach that includes the perspectives of older adults with lived experience, caregivers and other stakeholders; (ii) gaps in previous guidelines; (iii) recent developments in e-health and (iv) implementation across locations with limited access to resources such as low- and middle-income countries. a steering committee and a worldwide multidisciplinary group of experts and stakeholders, including older adults, were assembled. Geriatrics and gerontological societies were represented. Using a modified Delphi process, recommendations from 11 topic-specific working groups (WGs), 10 ad-hoc WGs and a WG dealing with the perspectives of older adults were reviewed and refined. The final recommendations were determined by voting. all older adults should be advised on falls prevention and physical activity. Opportunistic case finding for falls risk is recommended for community-dwelling older adults. Those considered at high risk should be offered a comprehensive multifactorial falls risk assessment with a view to co-design and implement personalised multidomain interventions. Other recommendations cover details of assessment and intervention components and combinations, and recommendations for specific settings and populations. the core set of recommendations provided will require flexible implementation strategies that consider both local context and resources.
Linkhttp://doi.org/10.1093/ageing/afac205
TitlePrevention of stroke: a global perspective.
AuthorsPandian, JD; Gall, SL; Kate, MP; Silva, GS; Akinyemi, RO; Ovbiagele, BI; Lavados, PM; Gandhi, DBC; Thrift, AG
JournalLancet (London, England)
Publication Date6 Oct 2018
Date Added to PubMed16 Oct 2018
AbstractAlong with the rising global burden of disability attributed to stroke, costs of stroke care are rising, providing the impetus to direct our research focus towards effective measures of stroke prevention. In this Series paper, we discuss strategies for reducing the risk of the emergence of disease (primordial prevention), preventing the onset of disease (primary prevention), and preventing the recurrence of disease (secondary prevention). Our focus includes global strategies and campaigns, and measurements of the effectiveness of worldwide preventive interventions, with an emphasis on low-income and middle-income countries. Our findings reveal that effective tobacco control, adequate nutrition, and development of healthy cities are important strategies for primordial prevention, whereas polypill strategies, use of mobile technology (mHealth), along with salt reduction and other dietary interventions, are effective in the primary prevention of stroke. An effective collaboration between various health-care sectors, government policies, and campaigns can successfully implement secondary prevention strategies, through surveillance and registries, such as the WHO's non-communicable diseases programmes, across high-income and low-income countries.
Linkhttp://doi.org/10.1016/S0140-6736(18)31269-8
TitleFactors Influencing Adherence to mHealth Apps for Prevention or Management of Noncommunicable Diseases: Systematic Review.
AuthorsJakob, R; Harperink, S; Rudolf, AM; Fleisch, E; Haug, S; Mair, JL; Salamanca-Sanabria, A; Kowatsch, T
JournalJournal of medical Internet research
Publication Date25 May 2022
Date Added to PubMed26 May 2022
AbstractMobile health (mHealth) apps show vast potential in supporting patients and health care systems with the increasing prevalence and economic costs of noncommunicable diseases (NCDs) worldwide. However, despite the availability of evidence-based mHealth apps, a substantial proportion of users do not adhere to them as intended and may consequently not receive treatment. Therefore, understanding the factors that act as barriers to or facilitators of adherence is a fundamental concern in preventing intervention dropouts and increasing the effectiveness of digital health interventions. This review aimed to help stakeholders develop more effective digital health interventions by identifying factors influencing the continued use of mHealth apps targeting NCDs. We further derived quantified adherence scores for various health domains to validate the qualitative findings and explore adherence benchmarks. A comprehensive systematic literature search (January 2007 to December 2020) was conducted on MEDLINE, Embase, Web of Science, Scopus, and ACM Digital Library. Data on intended use, actual use, and factors influencing adherence were extracted. Intervention-related and patient-related factors with a positive or negative influence on adherence are presented separately for the health domains of NCD self-management, mental health, substance use, nutrition, physical activity, weight loss, multicomponent lifestyle interventions, mindfulness, and other NCDs. Quantified adherence measures, calculated as the ratio between the estimated intended use and actual use, were derived for each study and compared with the qualitative findings. The literature search yielded 2862 potentially relevant articles, of which 99 (3.46%) were included as part of the inclusion criteria. A total of 4 intervention-related factors indicated positive effects on adherence across all health domains: personalization or tailoring of the content of mHealth apps to the individual needs of the user, reminders in the form of individualized push notifications, user-friendly and technically stable app design, and personal support complementary to the digital intervention. Social and gamification features were also identified as drivers of app adherence across several health domains. A wide variety of patient-related factors such as user characteristics or recruitment channels further affects adherence. The derived adherence scores of the included mHealth apps averaged 56.0% (SD 24.4%). This study contributes to the scarce scientific evidence on factors that positively or negatively influence adherence to mHealth apps and is the first to quantitatively compare adherence relative to the intended use of various health domains. As underlying studies mostly have a pilot character with short study durations, research on factors influencing adherence to mHealth apps is still limited. To facilitate future research on mHealth app adherence, researchers should clearly outline and justify the app's intended use; report objective data on actual use relative to the intended use; and, ideally, provide long-term use and retention data.
Linkhttp://doi.org/10.2196/35371
TitleDiabetes and COVID-19: The past, the present, and the future.
AuthorsPranata, R; Henrina, J; Raffaello, WM; Lawrensia, S; Huang, I
JournalMetabolism: clinical and experimental
Publication Date1 Aug 2021
Date Added to PubMed14 Jun 2021
AbstractDiabetes, one of the most prevalent chronic diseases in the world, is strongly associated with a poor prognosis in COVID-19. Scrupulous blood sugar management is crucial, since the worse outcomes are closely associated with higher blood sugar levels in COVID-19 infection. Although recent observational studies showed that insulin was associated with mortality, it should not deter insulin use in hospitalized patients requiring tight glucose control. Back and forth dilemma in the past with regards to continue/discontinue certain medications used in diabetes have been mostly resolved. The initial fears of consequences related to continuing certain medications have been largely dispelled. COVID-19 also necessitates the transformation in diabetes care through the integration of technologies. Recent advances in health-related technologies, notably telemedicine and remote continuous glucose monitoring, have become essential in the management of diabetes during the pandemic. Today, these technologies have changed the landscape of medicine and become more important than ever. Being a high-risk population, patients with type 1 or type 2 diabetes, should be prioritized for vaccination. In the future, as the pandemic fades, the prevalence of non-communicable diseases is expected to rise due to lifestyle changes and medical issues/dilemma encountered during the pandemic.
Linkhttp://doi.org/10.1016/j.metabol.2021.154814
TitleFacilitators and Barriers to Chronic Disease Self-Management and Mobile Health Interventions for People Living With Diabetes and Hypertension in Cambodia: Qualitative Study.
AuthorsSteinman, L; Heang, H; van Pelt, M; Ide, N; Cui, H; Rao, M; LoGerfo, J; Fitzpatrick, A
JournalJMIR mHealth and uHealth
Publication Date24 Apr 2020
Date Added to PubMed25 Apr 2020
AbstractIn many low- and middle-income countries (LMICs), heart disease and stroke are the leading causes of death as cardiovascular risk factors such as diabetes and hypertension rapidly increase. The Cambodian nongovernmental organization, MoPoTsyo, trains local residents with diabetes to be peer educators (PEs) to deliver chronic disease self-management training and medications to 14,000 people with hypertension and/or diabetes in Cambodia. We collaborated with MoPoTsyo to develop a mobile-based messaging intervention (mobile health; mHealth) to link MoPoTsyo's database, PEs, pharmacies, clinics, and people living with diabetes and/or hypertension to improve adherence to evidence-based treatment guidelines. This study aimed to understand the facilitators and barriers to chronic disease management and the acceptability, appropriateness, and feasibility of mHealth to support chronic disease management and strengthen community-clinical linkages to existing services. We conducted an exploratory qualitative study using semistructured interviews and focus groups with PEs and people living with diabetes and/or hypertension. Interviews were recorded and conducted in Khmer script, transcribed and translated into the English language, and uploaded into Atlas.ti for analysis. We used a thematic analysis to identify key facilitators and barriers to disease management and opportunities for mHealth content and format. The information-motivation-behavioral model was used to guide data collection, analysis, and message development. We conducted six focus groups (N=59) and 11 interviews in one urban municipality and five rural operating districts from three provinces in October 2016. PE network participants desired mHealth to address barriers to chronic disease management through reminders about medications, laboratory tests and doctor's consultations, education on how to incorporate self-management into their daily lives, and support for obstacles to disease management. Participants preferred mobile-based voice messages to arrive at dinnertime for improved phone access and family support. They desired voice messages over texts to communicate trust and increase accessibility for persons with limited literacy, vision, and smartphone access. PEs shared similar views and perceived mHealth as acceptable and feasible for supporting their work. We developed 34 educational, supportive, and reminder mHealth messages based on these findings. These mHealth messages are currently being tested in a cluster randomized controlled trial (#1R21TW010160) to improve diabetes and hypertension control in Cambodia. This study has implications for practice and policies in Cambodia and other LMICs and low-resource US settings that are working to engage PEs and build community-clinical linkages to facilitate chronic disease management.
Linkhttp://doi.org/10.2196/13536
TitleMobile Health Technology to Improve Care for Patients With Atrial Fibrillation.
AuthorsGuo, Y; Lane, DA; Wang, L; Zhang, H; Wang, H; Zhang, W; Wen, J; Xing, Y; Wu, F; Xia, Y; Liu, T; Wu, F; Liang, Z; Liu, F; Zhao, Y; Li, R; Li, X; Zhang, L; Guo, J; Burnside, G; Chen, Y; Lip, GYH; Guo, Y; Lip, GYH; Lane, DA; Chen, Y; Wang, L; Eckstein, J; Thomas, GN; Tong, L; Mei, F; Xuejun, L; Xiaoming, L; Zhaoliang, S; Xiangming, S; Wei, Z; Yunli, X; Jing, W; Fan, W; Sitong, Y; Xiaoqing, J; Bo, Y; Xiaojuan, B; Yuting, J; Yangxia, L; Yingying, S; Zhongju, T; Li, Y; Tianzhu, L; Chunfeng, N; Lili, Z; Shuyan, L; Zulu, W; Bing, X; Liming, L; Yuanzhe, J; Yunlong, X; Xiaohong, C; Fang, W; Lina, Z; Yihong, S; Shujie, J; Jing, L; Nan, L; Shijun, L; Huixia, L; Rong, L; Fan, L; Qingfeng, G; Tianyun, G; Yuan, W; Xin, L; Yan, R; Xiaoping, C; Ronghua, C; Yun, S; Yulan, Z; Haili, S; Yujie, Z; Quanchun, W; Weidong, S; Lin, W; Chan, E; Guangliang, S; Chen, Y; Wei, Z; Dandi, C; Xiang, H; Anding, X; Xiaohan, F; Ziqiang, Y; Xiang, G; Fulin, G
JournalJournal of the American College of Cardiology
Publication Date7 Apr 2020
Date Added to PubMed4 Apr 2020
AbstractCurrent management of patients with atrial fibrillation (AF) is limited by low detection of AF, non-adherence to guidelines, and lack of consideration of patients' preferences, thus highlighting the need for a more holistic and integrated approach to AF management. The objective of this study was to determine whether a mobile health (mHealth) technology-supported AF integrated management strategy would reduce AF-related adverse events, compared with usual care. This is a cluster randomized trial of patients with AF older than 18 years of age who were enrolled in 40 cities in China. Recruitment began on June 1, 2018 and follow-up ended on August 16, 2019. Patients with AF were randomized to receive usual care, or integrated care based on a mobile AF Application (mAFA) incorporating the ABC (Atrial Fibrillation Better Care) Pathway: A, Avoid stroke; B, Better symptom management; and C, Cardiovascular and other comorbidity risk reduction. The primary composite outcome was a composite of stroke/thromboembolism, all-cause death, and rehospitalization. Rehospitalization alone was a secondary outcome. Cardiovascular events were assessed using Cox proportional hazard modeling after adjusting for baseline risk. There were 1,646 patients allocated to mAFA intervention (mean age, 67.0 years; 38.0% female) with mean follow-up of 262 days, whereas 1,678 patients were allocated to usual care (mean age, 70.0 years; 38.0% female) with mean follow-up of 291 days. Rates of the composite outcome of 'ischemic stroke/systemic thromboembolism, death, and rehospitalization' were lower with the mAFA intervention compared with usual care (1.9% vs. 6.0%; hazard ratio [HR]: 0.39; 95% confidence interval [CI]: 0.22 to 0.67; p < 0.001). Rates of rehospitalization were lower with the mAFA intervention (1.2% vs. 4.5%; HR: 0.32; 95% CI: 0.17 to 0.60; p < 0.001). Subgroup analyses by sex, age, AF type, risk score, and comorbidities demonstrated consistently lower HRs for the composite outcome for patients receiving the mAFA intervention compared with usual care (all p < 0.05). An integrated care approach to holistic AF care, supported by mHealth technology, reduces the risks of rehospitalization and clinical adverse events. (Mobile Health [mHealth] technology integrating atrial fibrillation screening and ABC management approach trial; ChiCTR-OOC-17014138).
Linkhttp://doi.org/10.1016/j.jacc.2020.01.052
Title[Synthesis of evidence and recommendations: guidelines for cervical cancer screening, detection, and treatmentSíntese de evidências e recomendações: diretrizes para rastreamento, detecção e tratamento do câncer do colo do útero].
Authors
JournalRevista panamericana de salud publica = Pan American journal of public health
Publication Date1 Dec 2023
Date Added to PubMed24 Apr 2023
AbstractSynthesize the recommendations developed by the World Health Organization (WHO) for the screening and treatment of women with pre-cancerous lesions for cervical cancer prevention, with a view to improving the quality of care and health outcomes. The guidelines prepared by WHO follow the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) method for the preparation of guidelines, as set forth in the WHO Handbook for Guideline Development. A synthesis of the recommendations of two WHO guidelines was carried out. Additionally, a systematic search was conducted in PubMed, Lilacs, Mhealth Systems Evidence, Epistemonikos and gray literature of studies developed in the Americas to identify barriers, facilitators, implementation strategies, and indicators. A total of 19 recommendations and ten good practices were formulated for screening pre-cancerous lesions of the cervix and treating cervical cancer. Implementation barriers and facilitators were identified, and indicators were created for assessing adherence and outcomes. The recommendations provide guidance for the screening and treatment of women with pre-cancerous lesions for cervical cancer prevention, with a view to improving the quality of care and health outcomes. Implementation in Latin America and the Caribbean is considered. Organización Panamericana de la SaludspaCase ReportsEnglish AbstractSíntesis de evidencia y recomendaciones: directriz para el tamizaje, la detección y el tratamiento del cáncer de cuello uterino.20230421United StatesRev Panam Salud Publica97054001020-4989Sintetizar las recomendaciones desarrolladas por la Organización Mundial de la Salud (OMS) con el fin de mejorar la calidad del cuidado y los desenlaces en salud sobre el tamizaje y tratamiento de las mujeres con lesiones precancerosas para la prevención del cáncer de cuello uterino. Las directrices elaboradas por la OMS siguen los métodos de elaboración de la directriz GRADE (Grading of Recommendations Assessment Development and Evaluation) del Manual para el desarrollo de directrices de la OMS. Se llevó a cabo una síntesis de las recomendaciones de dos directrices de OMS. Adicionalmente, se realizó una búsqueda sistemática en PubMed, Lilacs, Health Systems Evidence, Epistemonikos y literatura gris de estudios desarrollados en las Américas con el fin de identificar barreras, facilitadores, estrategias de implementación e indicadores. Se formularon 19 recomendaciones y 10 puntos de buena práctica para el tamizaje de lesiones precancerosas del cuello del útero y el tratamiento del cáncer de cuello uterino. Se identificaron barreras y facilitadores para la implementación y se crearon indicadores de adherencia y resultado. Las recomendaciones formuladas proveen orientación para mejorar la calidad del cuidado y los desenlaces en salud sobre el tamizaje y tratamiento de las mujeres con lesiones precancerosas para la prevención del cáncer de cuello uterino, con consideraciones para su implementación en América Latina y el Caribe. Apresentar de forma resumida as recomendações desenvolvidas pela Organização Mundial da Saúde (OMS) para melhorar a qualidade da atenção e os desfechos de saúde relacionados ao rastreamento e ao tratamento de mulheres com lesões pré-cancerosas para a prevenção do câncer do colo do útero. As diretrizes elaboradas pela OMS seguem o método GRADE (Grading of Recommendations Assessment, Development and Evaluation) do manual de desenvolvimento de diretrizes da OMS. Fez-se uma síntese das recomendações de duas diretrizes da OMS. Além disso, realizou-se uma busca sistemática nos bancos de dados PubMed, Lilacs, mHealth Systems Evidence e Epistemonikos e na literatura cinzenta por estudos realizados nas Américas, a fim de identificar barreiras, facilitadores, estratégias de implementação e indicadores. Foram formuladas 19 recomendações e 10 pontos de boas práticas para o rastreamento de lesões pré-cancerosas do colo do útero e o tratamento do câncer do colo do útero. Identificaram-se facilitadores e barreiras para implementação e foram criados indicadores de adesão e de resultados. As recomendações apresentadas fornecem orientações para melhorar a qualidade da atenção e os desfechos de saúde no rastreamento e no tratamento de mulheres com lesões pré-cancerosas para a prevenção do câncer do colo do útero, com considerações para sua implementação na América Latina e no Caribe.
Linkhttp://doi.org/10.26633/RPSP.2023.72
TitleFighting obesity in children from European World Health Organization member states. Epidemiological data, medical-social aspects, and prevention programs.
AuthorsNittari, G; Scuri, S; Petrelli, F; Pirillo, I; di Luca, NM; Grappasonni, I
JournalLa Clinica terapeutica
Publication Date1 Dec 2019
Date Added to PubMed8 Jun 2019
AbstractChildhood obesity is one of the most serious public health chal-lenges of this century. Overweight and obese children are likely to stay obese into adulthood and more likely to develop non-communicable diseases like diabetes and cardiovascular diseases at a younger age. In the WHO European Region one child out of 3, is overweight or obese. Over 60% of children who are overweight before puberty will be overweight in early adulthood. Children and adolescents, aged 5-19 have shown rising obesity rates in almost all nations, including where the situation was far from alarming 40 years ago. Several nations have seen the prevalence almost double: Israel has gone from 5.8% in 1975 to 11.9% in 2016, Andorra from 6.2% to 12.8%, and Malta from 7.4% to 13.4%. Analyzing overweight and obesity, we can see that they follow similar trends and patterns. In 1975 the majority of European countries had a prevalence less than 10% and obesity less than 5%, while no European country had overweight prevalence higher than 30% and obe-sity higher than 10%. In 2016 the trend reversed, showing a worrying increase in the number of European countries with a high prevalence of overweight (over 30%) and obesity (over 10%) (Fig. 1)(29). Starting from the analysis of epidemiological data on obesity in the WHO European Region, the paper analyzes the adopted prevention programs in order to assess their effectiveness and figure out the best strategies to reduce the prevalence of overweight and obesity. The WHO European Childhood Obesity Surveillance Initiative reported that children tend to overeat and not to do enough physical exercise. Different preventive programs have identified different areas of action and corresponding measures: consumption of healthy foods, physical exercise, care before conception and during pregnancy, early childhood, school age children, weight management, monitoring and evaluation. Primary prevention is essential to reduce obesity incidence: it is easier to act on the adoption of healthy eating habits than intervene with diets on children who already have weight issues. Working on pre-vention programs represents an investment for the future of children's health. By simply acting on prevention, particularly on body weight reduction, it could be possible to tackle the spreading of correlated di-seases. Therefore, prevention programs ought to be prioritized priority at a national and international level.
Linkhttp://doi.org/10.7417/CT.2019.2137
TitleEstimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study.
AuthorsJames, SL; Castle, CD; Dingels, ZV; Fox, JT; Hamilton, EB; Liu, Z; Roberts, NLS; Sylte, DO; Bertolacci, GJ; Cunningham, M; Henry, NJ; LeGrand, KE; Abdelalim, A; Abdollahpour, I; Abdulkader, RS; Abedi, A; Abegaz, KH; Abosetugn, AE; Abushouk, AI; Adebayo, OM; Adsuar, JC; Advani, SM; Agudelo-Botero, M; Ahmad, T; Ahmed, MB; Ahmed, R; Eddine Aichour, MT; Alahdab, F; Alanezi, FM; Alema, NM; Alemu, BW; Alghnam, SA; Ali, BA; Ali, S; Alinia, C; Alipour, V; Aljunid, SM; Almasi-Hashiani, A; Almasri, NA; Altirkawi, K; Abdeldayem Amer, YS; Andrei, CL; Ansari-Moghaddam, A; T Antonio, CA; Anvari, D; Yaw Appiah, SC; Arabloo, J; Arab-Zozani, M; Arefi, Z; Aremu, O; Ariani, F; Arora, A; Asaad, M; Ayala Quintanilla, BP; Ayano, G; Ayanore, MA; Azarian, G; Badawi, A; Badiye, AD; Baig, AA; Bairwa, M; Bakhtiari, A; Balachandran, A; Banach, M; Banerjee, SK; Banik, PC; Banstola, A; Barker-Collo, SL; Bärnighausen, TW; Barzegar, A; Bayati, M; Bazargan-Hejazi, S; Bedi, N; Behzadifar, M; Belete, H; Bennett, DA; Bensenor, IM; Berhe, K; Bhagavathula, AS; Bhardwaj, P; Bhat, AG; Bhattacharyya, K; Bhutta, ZA; Bibi, S; Bijani, A; Boloor, A; Borges, G; Borschmann, R; Borzì, AM; Boufous, S; Braithwaite, D; Briko, NI; Brugha, T; Budhathoki, SS; Car, J; Cárdenas, R; Carvalho, F; Castaldelli-Maia, JM; Castañeda-Orjuela, CA; Castelpietra, G; Catalá-López, F; Cerin, E; Chandan, JS; Chapman, JR; Chattu, VK; Chattu, SK; Chatziralli, I; Chaudhary, N; Cho, DY; Choi, JJ; Kabir Chowdhury, MA; Christopher, DJ; Chu, DT; Cicuttini, FM; Coelho, JM; Costa, VM; Dahlawi, SMA; Daryani, A; Dávila-Cervantes, CA; Leo, D; Demeke, FM; Demoz, GT; Demsie, DG; Deribe, K; Desai, R; Nasab, MD; Silva, DDD; Dibaji Forooshani, ZS; Do, HT; Doyle, KE; Driscoll, TR; Dubljanin, E; Adema, BD; Eagan, AW; Elemineh, DA; El-Jaafary, SI; El-Khatib, Z; Ellingsen, CL; Zaki, MES; Eskandarieh, S; Eyawo, O; Faris, PS; Faro, A; Farzadfar, F; Fereshtehnejad, SM; Fernandes, E; Ferrara, P; Fischer, F; Folayan, MO; Fomenkov, AA; Foroutan, M; Francis, JM; Franklin, RC; Fukumoto, T; Geberemariyam, BS; Gebremariam, H; Gebremedhin, KB; Gebremeskel, LG; Gebremeskel, GG; Gebremichael, B; Gedefaw, GA; Geta, B; Getenet, AB; Ghafourifard, M; Ghamari, F; Gheshlagh, RG; Gholamian, A; Gilani, SA; Gill, TK; Goudarzian, AH; Goulart, AC; Grada, A; Grivna, M; Guimarães, RA; Guo, Y; Gupta, G; Haagsma, JA; Hall, BJ; Hamadeh, RR; Hamidi, S; Handiso, DW; Haro, JM; Hasanzadeh, A; Hassan, S; Hassanipour, S; Hassankhani, H; Hassen, HY; Havmoeller, R; Hendrie, D; Heydarpour, F; Híjar, M; Ho, HC; Hoang, CL; Hole, MK; Holla, R; Hossain, N; Hosseinzadeh, M; Hostiuc, S; Hu, G; Ibitoye, SE; Ilesanmi, OS; Inbaraj, LR; Naghibi Irvani, SS; Mofizul Islam, M; Shariful Islam, SM; Ivers, RQ; Jahani, MA; Jakovljevic, M; Jalilian, F; Jayaraman, S; Jayatilleke, AU; Jha, RP; John-Akinola, YO; Jonas, JB; Jones, KM; Joseph, N; Joukar, F; Jozwiak, JJ; Jungari, SB; Jürisson, M; Kabir, A; Kahsay, A; Kalankesh, LR; Kalhor, R; Kamil, TA; Kanchan, T; Kapoor, N; Karami, M; Kasaeian, A; Kassaye, HG; Kavetskyy, T; Kayode, GA; Keiyoro, PN; Kelbore, AG; Khader, YS; Khafaie, MA; Khalid, N; Khalil, IA; Khalilov, R; Khan, M; Khan, EA; Khan, J; Khanna, T; Khazaei, S; Khazaie, H; Khundkar, R; Kiirithio, DN; Kim, YE; Kim, YJ; Kim, D; Kisa, S; Kisa, A; Komaki, H; Kondlahalli, SKM; Koolivand, A; Korshunov, VA; Koyanagi, A; Kraemer, MUG; Krishan, K; Defo, BK; Bicer, BK; Kugbey, N; Kumar, N; Kumar, M; Kumar, V; Kumar, N; Kumaresh, G; Lami, FH; Lansingh, VC; Lasrado, S; Latifi, A; Lauriola, P; Vecchia, C; Leasher, JL; Huey Lee, SW; Li, S; Liu, X; Lopez, AD; Lotufo, PA; Lyons, RA; Machado, DB; Madadin, M; Abd El Razek, MM; Mahotra, NB; Majdan, M; Majeed, A; Maled, V; Malta, DC; Manafi, N; Manafi, A; Manda, AL; Manjunatha, N; Mansour-Ghanaei, F; Mansournia, MA; Maravilla, JC; Mason-Jones, AJ; Masoumi, SZ; Massenburg, BB; Maulik, PK; Mehndiratta, MM; Melketsedik, ZA; Memiah, PTN; Mendoza, W; Menezes, RG; Mengesha, MM; Meretoja, TJ; Meretoja, A; Merie, HE; Mestrovic, T; Miazgowski, B; Miazgowski, T; Miller, TR; Mini, GK; Mirica, A; Mirrakhimov, EM; Mirzaei-Alavijeh, M; Mithra, P; Moazen, B; Moghadaszadeh, M; Mohamadi, E; Mohammad, Y; Darwesh, AM; Mohammadian-Hafshejani, A; Mohammadpourhodki, R; Mohammed, S; Mohammed, JA; Mohebi, F; Mohseni Bandpei, MA; Molokhia, M; Monasta, L; Moodley, Y; Moradi, M; Moradi, G; Moradi-Lakeh, M; Moradzadeh, R; Morawska, L; Velásquez, IM; Morrison, SD; Mossie, TB; Muluneh, AG; Musa, KI; Mustafa, G; Naderi, M; Nagarajan, AJ; Naik, G; Naimzada, MD; Najafi, F; Nangia, V; Nascimento, BR; Naserbakht, M; Nayak, V; Nazari, J; Ndwandwe, DE; Negoi, I; Ngunjiri, JW; Nguyen, TH; Nguyen, CT; Nguyen, DN; Thi Nguyen, HL; Nikbakhsh, R; Anggraini Ningrum, DN; Nnaji, CA; Ofori-Asenso, R; Ogbo, FA; Oghenetega, OB; Oh, IH; Olagunju, AT; Olagunju, TO; Bali, AO; Onwujekwe, OE; Orpana, HM; Ota, E; Otstavnov, N; Otstavnov, SS; P A, M; Padubidri, JR; Pakhale, S; Pakshir, K; Panda-Jonas, S; Park, EK; Patel, SK; Pathak, A; Pati, S; Paulos, K; Peden, AE; Filipino Pepito, VC; Pereira, J; Phillips, MR; Polibin, RV; Polinder, S; Pourmalek, F; Pourshams, A; Poustchi, H; Prakash, S; Angga Pribadi, DR; Puri, P; Syed, ZQ; Rabiee, N; Rabiee, M; Radfar, A; Rafay, A; Rafiee, A; Rafiei, A; Rahim, F; Rahimi, S; Rahman, MA; Rajabpour-Sanati, A; Rajati, F; Rakovac, I; Rao, SJ; Rashedi, V; Rastogi, P; Rathi, P; Rawaf, S; Rawal, L; Rawassizadeh, R; Renjith, V; Resnikoff, S; Rezapour, A; Ribeiro, AI; Rickard, J; Rios González, CM; Roever, L; Ronfani, L; Roshandel, G; Saddik, B; Safarpour, H; Safdarian, M; Mohammad Sajadi, S; Salamati, P; Rashad Salem, MR; Salem, H; Salz, I; Samy, AM; Sanabria, J; Riera, LS; Santric Milicevic, MM; Sarker, AR; Sarveazad, A; Sathian, B; Sawhney, M; Sayyah, M; Schwebel, DC; Seedat, S; Senthilkumaran, S; Seyedmousavi, S; Sha, F; Shaahmadi, F; Shahabi, S; Shaikh, MA; Shams-Beyranvand, M; Sheikh, A; Shigematsu, M; Shin, JI; Shiri, R; Siabani, S; Sigfusdottir, ID; Singh, JA; Singh, PK; Sinha, DN; Soheili, A; Soriano, JB; Sorrie, MB; Soyiri, IN; Stokes, MA; Sufiyan, MB; Sykes, BL; Tabarés-Seisdedos, R; Tabb, KM; Taddele, BW; Tefera, YM; Tehrani-Banihashemi, A; Tekulu, GH; Tesema Tesema, AK; Tesfay, BE; Thapar, R; Titova, MV; Tlaye, KG; Tohidinik, HR; Topor-Madry, R; Tran, KB; Tran, BX; Tripathy, JP; Tsai, AC; Tsatsakis, A; Car, LT; Ullah, I; Ullah, S; Unnikrishnan, B; Upadhyay, E; Uthman, OA; Valdez, PR; Vasankari, TJ; Veisani, Y; Venketasubramanian, N; Violante, FS; Vlassov, V; Waheed, Y; Wang, YP; Wiangkham, T; Wolde, HF; Woldeyes, DH; Wondmeneh, TG; Wondmieneh, AB; Wu, AM; Wyper, GMA; Yadav, R; Yadollahpour, A; Yano, Y; Yaya, S; Yazdi-Feyzabadi, V; Ye, P; Yip, P; Yisma, E; Yonemoto, N; Yoon, SJ; Youm, Y; Younis, MZ; Yousefi, Z; Yu, C; Yu, Y; Moghadam, TZ; Zaidi, Z; Zaman, SB; Zamani, M; Zandian, H; Zarei, F; Zhang, ZJ; Zhang, Y; Ziapour, A; Zodpey, S; Dandona, R; Dharmaratne, SD; Hay, SI; Mokdad, AH; Pigott, DM; Reiner, RC; Vos, T
JournalInjury prevention : journal of the International Society for Child and Adolescent Injury Prevention
Publication Date1 Oct 2020
Date Added to PubMed26 Aug 2020
AbstractWhile there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates with sufficient demographic, geographical and temporal detail to be useful for policy makers. The Global Burden of Disease (GBD) 2017 study used methods to provide highly detailed estimates of global injury burden that meet these criteria. In this study, we report and discuss the methods used in GBD 2017 for injury morbidity and mortality burden estimation. In summary, these methods included estimating cause-specific mortality for every cause of injury, and then estimating incidence for every cause of injury. Non-fatal disability for each cause is then calculated based on the probabilities of suffering from different types of bodily injury experienced. GBD 2017 produced morbidity and mortality estimates for 38 causes of injury. Estimates were produced in terms of incidence, prevalence, years lived with disability, cause-specific mortality, years of life lost and disability-adjusted life-years for a 28-year period for 22 age groups, 195 countries and both sexes. GBD 2017 demonstrated a complex and sophisticated series of analytical steps using the largest known database of morbidity and mortality data on injuries. GBD 2017 results should be used to help inform injury prevention policy making and resource allocation. We also identify important avenues for improving injury burden estimation in the future.
Linkhttp://doi.org/10.1136/injuryprev-2019-043531
TitleEnd User and Implementer Experiences of mHealth Technologies for Noncommunicable Chronic Disease Management in Young Adults: Systematic Review.
AuthorsSlater, H; Campbell, JM; Stinson, JN; Burley, MM; Briggs, AM
JournalJournal of medical Internet research
Publication Date12 Dec 2017
Date Added to PubMed14 Dec 2017
AbstractChronic noncommunicable diseases (NCDs) such as asthma, diabetes, cancer, and persistent musculoskeletal pain impose an escalating and unsustainable burden on young people, their families, and society. Exploring how mobile health (mHealth) technologies can support management for young people with NCDs is imperative. The aim of this study was to identify, appraise, and synthesize available qualitative evidence on users' experiences of mHealth technologies for NCD management in young people. We explored the perspectives of both end users (young people) and implementers (health policy makers, clinicians, and researchers). A systematic review and meta-synthesis of qualitative studies. Eligibility criteria included full reports published in peer-reviewed journals from January 2007 to December 2016, searched across databases including EMBASE, MEDLINE (PubMed), Scopus, and PsycINFO. All qualitative studies that evaluated the use of mHealth technologies to support young people (in the age range of 15-24 years) in managing their chronic NCDs were considered. Two independent reviewers identified eligible reports and conducted critical appraisal (based on the Joanna Briggs Institute Qualitative Assessment and Review Instrument: JBI-QARI). Three reviewers independently, then collaboratively, synthesized and interpreted data through an inductive and iterative process to derive emergent themes across the included data. External validity checking was undertaken by an expert clinical researcher and for relevant content, a health policy expert. Themes were subsequently subjected to a meta-synthesis, with findings compared and contrasted between user groups and policy and practice recommendations derived. Twelve studies met our inclusion criteria. Among studies of end users (N=7), mHealth technologies supported the management of young people with diabetes, cancer, and asthma. Implementer studies (N=5) covered the management of cognitive and communicative disabilities, asthma, chronic self-harm, and attention deficit hyperactivity disorder. Quality ratings were higher for implementer compared with end user studies. Both complementary and unique user themes emerged. Themes derived for end users of mHealth included (1) Experiences of functionality that supported self-management, (2) Acceptance (technical usability and feasibility), (3) Importance of codesign, and (4) Perceptions of benefit (self-efficacy and empowerment). For implementers, derived themes included (1) Characteristics that supported self-management (functional, technical, and behavior change); (2) Implementation challenges (systems level, service delivery level, and clinical level); (3) Adoption considerations for specific populations (training end users; specific design requirements); and (4) Codesign and tailoring to facilitate uptake and person-centered care. Synthesizing available data revealed both complementary and unique user perspectives on enablers and barriers to designing, developing, and implementing mHealth technologies to support young people's management of their chronic NCDs. PROSPERO CRD42017056317; http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD 42017056317 (Archived by WebCite at http://www.webcitation.org/6vZ5UkKLp).
Linkhttp://doi.org/10.2196/jmir.8888
MNCHFPRHHIV/AIDSMalariaNoncommunicable diseaseCOVID-19Decision-makingEducation & trainingBehavior changeGovernancePrivacy & securityEquityCHWsYouth & adolescentsSystematic reviewsProtocols & research designMedical RecordsLaboratoryPharmacyHuman ResourcesmHealthSMSChatbotsAI